FI942938L - Soy protein or hydrolysates in pharmaceutical compositions as protection of bioactive peptides against enzymatic inactivation - Google Patents

Soy protein or hydrolysates in pharmaceutical compositions as protection of bioactive peptides against enzymatic inactivation Download PDF

Info

Publication number: FI942938L
Authority: FI; Finland
Prior art keywords: hydrolysates; protection; pharmaceutical compositions; soy protein; bioactive peptides
Prior art date: 1991-12-18

Application number

FI942938A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI942938A0 (en

FI942938A7 (en

Inventor

Gordon L Amidon

Glen D Leesman

Patrick J Sinko

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-18

Filing date

1992-11-09

Publication date

1994-06-17

1992-11-09 Application filed by Pfizer filed Critical Pfizer

1994-06-17 Publication of FI942938A0 publication Critical patent/FI942938A0/en

1994-06-17 Publication of FI942938A7 publication Critical patent/FI942938A7/en

1994-06-17 Publication of FI942938L publication Critical patent/FI942938L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Inorganic Chemistry (AREA)
Botany (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

FI942938A 1991-12-18 1992-11-09 Soy protein or hydrolysates in pharmaceutical compositions as protection of bioactive peptides against enzymatic inactivation FI942938L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81059391A	1991-12-18	1991-12-18
PCT/US1992/009336 WO1993011799A1 (en)	1991-12-18	1992-11-09	Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Publications (3)

Publication Number	Publication Date
FI942938A0 FI942938A0 (en)	1994-06-17
FI942938A7 FI942938A7 (en)	1994-06-17
FI942938L true FI942938L (en)	1994-06-17

Family

ID=25204183

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI942938A FI942938L (en)	1991-12-18	1992-11-09	Soy protein or hydrolysates in pharmaceutical compositions as protection of bioactive peptides against enzymatic inactivation

Country Status (12)

Country	Link
EP (1)	EP0617626A1 (en)
JP (1)	JPH06510796A (en)
AU (1)	AU3058392A (en)
CA (1)	CA2125400A1 (en)
FI (1)	FI942938L (en)
HU (1)	HUT69785A (en)
IL (1)	IL104048A0 (en)
MX (1)	MX9207407A (en)
NO (1)	NO942323D0 (en)
PT (1)	PT101135A (en)
WO (1)	WO1993011799A1 (en)
ZA (1)	ZA929761B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR950703333A (en) *	1992-10-02	1995-09-20	알렌 제이. 스피겔	Pharmaceutical Compositions Containing Nonionic Surfactants
WO1995006463A1 (en) *	1993-09-01	1995-03-09	Pfizer Inc.	Pharmaceutical compositions containing anionic surfactants
US6852690B1 (en)	1995-08-22	2005-02-08	Amylin Pharmaceuticals, Inc.	Method and composition for enhanced parenteral nutrition
DE19530865A1 (en) *	1995-08-22	1997-02-27	Michael Dr Med Nauck	Active ingredient and agent for parenteral nutrition
WO2001054514A1 (en) *	2000-01-27	2001-08-02	Aqua Solution Inc.	Composition for intestinal delivery
GB0015921D0 (en) *	2000-06-30	2000-08-23	Nat Biolog Standards Board	Improvements in or relating to stabilisation of substances
CL2008001640A1 (en) *	2007-06-08	2008-11-07	Bergen Teknologioverforing As	Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4537769A (en) *	1982-04-06	1985-08-27	American Cyanamid Company	Stabilization of influenza virus vaccine
IL68769A (en) *	1983-05-23	1986-02-28	Hadassah Med Org	Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) *	1985-06-14	1988-09-27	Albion International, Inc.	Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) *	1986-10-31	1993-05-29	Pfizer	Nor-statine and nor-cyclostatine polypeptides
GB2212062B (en) *	1987-11-13	1991-07-17	Isf Spa	Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer
EP0341661A3 (en) *	1988-05-11	1991-05-02	The Du Pont Merck Pharmaceutical Company	Peptide-drug compositions containing alpha-aminoboronic acid derivatives
DD273980B5 (en) *	1988-07-12	1994-04-14	Berlin Chemie Ag	Process for the preparation of insulin preparations for rectal use
GB8822857D0 (en) *	1988-09-29	1988-11-02	Patralan Ltd	Pharmaceutical formulations
DK546289D0 (en) *	1989-11-02	1989-11-02	Danochemo As	carotenoid

1992
- 1992-11-09 AU AU30583/92A patent/AU3058392A/en not_active Abandoned
- 1992-11-09 EP EP92924173A patent/EP0617626A1/en not_active Withdrawn
- 1992-11-09 FI FI942938A patent/FI942938L/en not_active Application Discontinuation
- 1992-11-09 HU HU9401824A patent/HUT69785A/en unknown
- 1992-11-09 WO PCT/US1992/009336 patent/WO1993011799A1/en not_active Application Discontinuation
- 1992-11-09 CA CA002125400A patent/CA2125400A1/en not_active Abandoned
- 1992-11-09 JP JP5510892A patent/JPH06510796A/en active Pending
- 1992-12-10 IL IL104048A patent/IL104048A0/en unknown
- 1992-12-16 PT PT101135A patent/PT101135A/en not_active Application Discontinuation
- 1992-12-17 MX MX9207407A patent/MX9207407A/en unknown
- 1992-12-17 ZA ZA929761A patent/ZA929761B/en unknown
1994
- 1994-06-17 NO NO942323A patent/NO942323D0/en unknown

Also Published As

Publication number	Publication date
FI942938A0 (en)	1994-06-17
EP0617626A1 (en)	1994-10-05
HUT69785A (en)	1995-09-28
CA2125400A1 (en)	1993-06-24
WO1993011799A1 (en)	1993-06-24
AU3058392A (en)	1993-07-19
IL104048A0 (en)	1993-05-13
FI942938A7 (en)	1994-06-17
NO942323L (en)	1994-06-17
PT101135A (en)	1994-03-31
ZA929761B (en)	1994-06-17
NO942323D0 (en)	1994-06-17
JPH06510796A (en)	1994-12-01
HU9401824D0 (en)	1994-09-28
MX9207407A (en)	1993-06-01

Similar Documents

Publication	Publication Date	Title
FI961819L (en)	1996-04-29	Protein:Substituted di- and tripeptide inhibitors of farnesyltransferase
DE69118535D1 (en)	1996-05-09	OSTEO-INDUCTIVE PHARMACEUTICAL FORMULATIONS
HUP0002942A3 (en)	2001-12-28	Peptides having serine protease inhibiting effect pharmaceutical compositions comprising thereof and their use
HUP0100669A3 (en)	2001-12-28	Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
IL134732A0 (en)	2001-04-30	Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
DE69532996D1 (en)	2004-06-09	PEPTIDE ANALOGS OF THE HUMAN BASIC MYELINE PROTEIN
DE69900746D1 (en)	2002-02-28	CONTROLLED ADMINISTRATION OF PEPTIDES OR PROTEINS
FI956310L (en)	1995-12-28	Stabilized pharmaceutical peptide compositions
IL109867A0 (en)	1994-10-07	alpha-heteroaryloxymethyl ketones as interleukin -1beta protease inhibitors and pharmaceutical compositions containing them
ATE204297T1 (en)	2001-09-15	PEPTIDE ANALOGUES OF LH-RH, THEIR USES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EE9700249A (en)	1998-04-15	Use of compound lipids as stabilizing additives in pharmaceutical preparations of digestive enzyme mixtures
SE0002202D0 (en)	2000-06-13	New peptides
ATE186541T1 (en)	1999-11-15	QUILLAJASAPONIN SUPPLEMENT AND VACCINE FORMULATION CONTAINING SAME
MX9708727A (en)	1997-12-31	Novel variants of apolipoprotein a-i.
DE69512929D1 (en)	1999-11-25	SALTS OF AMINO ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69810761D1 (en)	2003-02-20	SYNERGISTIC MIXTURES OF SELECTED AMINO ACIDS
FI963132L (en)	1996-08-09	Diastereomerically pure trifluoromethylketone peptide derivatives as inhibitors of human leukocyte elastase
ITMI951450A0 (en)	1995-07-06	ACYLIC ESTERS OF ACHIRAL AMINO ACIDS OF GANGICLOVIR AND THEIR DERIVATIVES
FI942938L (en)	1994-06-17	Soy protein or hydrolysates in pharmaceutical compositions as protection of bioactive peptides against enzymatic inactivation
AU7650000A (en)	2001-04-17	Use of basic amino acids as blow-drying protection agents in hair treatment products
EE200000694A (en)	2002-06-17	Formulation of recombinant human iterferon beta-1a (IFN-β-1a)
IT1277338B1 (en)	1997-11-10	PHARMACEUTICAL COMPOSITIONS OF CYCLOSPORINE OR OTHER PEPTIDE SUBSTANCES
CA2247998A1 (en)	1997-09-04	Fragments of cr1 and their use
BR9507063A (en)	1997-09-02	Peptide derived from peptide substitution and pharmaceutical composition
ATA114093A (en)	1996-04-15	MARKED ALPHA AMINO ACIDS

Legal Events

Date	Code	Title	Description
1999-06-30	FD	Application lapsed